Tscan therapeutics announces best abstracts award and upcoming oral presentation at the 2024 tandem meetings of astct and cibmtr

Presentation to include additional results from ongoing phase 1 study of tsc-100 and tsc-101 for the treatment of heme malignancies

TCRX Ratings Summary

TCRX Quant Ranking